Clearmind Medicine Gets U.S. Patent for Psychedelic Drug to Treat Alcoholism - Addiction/Recovery eBulletin

ALCOHOLISM MEDICATION? – 

Dec. 21, 2022 – The patent follows the appointment of former Red Bull Canada executive Nicholas Kadysh as special advisor on the regulatory development of MEAI.

Clearmind has been granted patent for MEAI-based alcohol substitute in Europe and India.

Click@SeekingAlpha